"triamcinolon injections" "NHG standard" "exercises" "efficacy" "shoulder complaints" "triamcinolon injecties"NHG standaard" "oefeningen" "effectiviteit" "schouder klachten"
Conditions
Interventions
Group A: a simultaneus intervention in which the patients will be injected with a combination of lidocaine and 1 ml Kenacort A40 and at the same time exercises
and group B in which the patient will be injected with a combination of lidocaine and 1 ml Kenacort A40 and after six weeks according to the NHG-standard with exercises.
Sponsors
dr.M.Reijman
Erasmus MC
Department of Orthopaedics
Room Hs-104
PO Box 2040
3000 CA Rotterdam
Email: m.reijman@erasmusmc.nl
tel: 010-4633642
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with shoulder complaints consulting their GP; 2. Presence of painfull-arc and restricted range of motion.
Exclusion criteria
Exclusion criteria: 1. Not signed informed consent form; 2. Age under 18 or above 70 year; 3. Treatment (exercises or corticosteroid injections) of shoulder complaints during the last 6 months; 4. Insufficient command of the Dutch language, spoken and/or written.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the change in pain in rest, during activities or during the night of the last 24 hours, between baseline and 78 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change compared to the baseline assessments of: 1. DASH questionnaire; 2. SF36 questionnaire; 3. Analgetica use; 4. Participant rated improvement; 5. Range of Motion maesurements; 6. Painful-Arc; 7. Complications of injections. | — |
Contacts
Public ContactB.J Berkhout
Vrieseweg 157
Outcome results
None listed